Cannabis Law Report

SEPTEMBER 23, 2019

In this position paper, cannabis is an overarching term used to refer to the plant Cannabis sativa. The regulatory environment surrounding cannabis, medical and recreational marijuana, and cannabidiol (CBD) is rapidly changing, along with the retail environment. Cannabis sativa with less than 0.3% Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JUNE 8, 2021

It’s all about one single component of Cannabis Sativa – cannabidiol. Currently, the development of effective drugs based on CBD for the treatment of Alzheimer’s disease, dementia, diabetes, and epilepsy is underway. But above all, they create a comfortable environment for investors. Why cannabis, you may ask?

Research and Development 98

Research and Development CBD Environment Supply Chain 98

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. The firm was founded in 1998 and listed on AIM in 2001 before it left London to join the NASDAQ in 2013.?Over

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40